Premium
An Indwelling Subcutaneous FEP Cannula for Intermittent Insulin Injection: Patient Experience and Effect on Diabetic Control
Author(s) -
Rayman G.,
Wise P. H.
Publication year - 1988
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/j.1464-5491.1988.tb01058.x
Subject(s) - cannula , medicine , bedtime , insulin , surgery , diabetes mellitus , anesthesia , subcutaneous injection , endocrinology
The acceptability and efficacy of injecting insulin through a subcutaneous FEP cannula (to reduce the frequency of needle pricks) compared with conventional multiple injection therapy was examined in a cross‐over study. Thirty‐two insulin‐dependent diabetic patients injected through the cannula for 10 weeks using a pen injector, followed by 10 weeks using the injector alone, or vice versa. Rapid‐acting insulin was given before meals and intermediate‐acting insulin at bedtime. Blood glucose control was not affected by cannula use (glycosylated haemoglobin: cannula, 8.6±0.3 %; no cannula, 8.6±0.3 %). Twenty‐two of the 30 patients completing the study preferred to use the cannula and 21 requested to continue using it. There were no complications associated with its use.